Posts by: Ana Pena

News

Results of the first year of newborn screening for X-linked adrenoleukodystrophy (X-ALD) in Minnesota showed that the birth prevalence of the disease is five times greater than previously anticipated, and ... Read more

May 21, 2019May 21, 2019

#AANAM – MGTA-456 Cell Therapy Shows Promise in cALD Patients 6 Months After Transplant, Trial Update Shows

News

MGTA-456, Magenta Therapeutics’ candidate stem cell therapy, continues to show promise for stabilizing neurological function and resolving brain inflammation in patients with cerebral adrenoleukodystrophy (cALD), six-month follow-up data from two ... Read more

January 15, 2019January 15, 2019

Changes in Cell Lipids May Help Explain Symptom Severity in X-ALD, Study Suggests

News

People with X-linked adrenoleukodystrophy (X-ALD) have an imbalance in the production of important fat molecules, or lipids, in their cells that may influence the symptoms and severity of the disease, a ... Read more

January 8, 2019January 8, 2019

Abnormal Immune Response May Underlie Severe Brain Inflammation in Cerebral ALD, Study Suggests

News

The abnormal behavior of immune cells called macrophages may be behind the development of cerebral adrenoleukodystrophy (CALD), a violent form of brain inflammation that affects many patients with X-linked adrenoleukodystrophy ... Read more